NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT02855944 2023-06-09ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patientspharmaand GmbHPhase 3 Completed349 enrolled 29 charts
NCT02759588 2023-01-05GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerGenelux CorporationPhase 1/2 Completed46 enrolled
NCT00318370 2015-09-09Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based ChemotherapyMorphotekPhase 2 Completed58 enrolled 12 charts